OraLiva, Inc.

OraLiva, Inc. is at the forefront of revolutionizing cancer diagnostics, focusing on the future of healthcare with its innovative solutions. Specializing in hospitals and health care, OraLiva is dedicated to pioneering a new era of non-invasive, AI-powered cytology, ultimately designed for use directly at the point of care. The company’s mission is to eliminate delays in cancer diagnosis and make lifesaving precision diagnostics accessible to every patient, everywhere.

OraLiva’s proprietary technology platform combines state-of-the-art biosensing with AI to analyze single-cell data from a simple brush sample. Within minutes, the test detects key cytologic signatures of dysplasia—the cellular warning signs that precede cancer—providing providers with lab-grade insight in real time. The primary address of OraLiva, Inc. is in New York, US.

OraLiva, Inc. is committed to enhancing the speed and accuracy of cancer diagnoses, ensuring that healthcare providers can make informed decisions promptly. OraLiva, Inc. continues to develop and refine its diagnostic tools, driving progress in the field of oncology. We invite the manager of OraLiva, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.